Adina Figl

2.4k total citations · 1 hit paper
8 papers, 1.6k citations indexed

About

Adina Figl is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Adina Figl has authored 8 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Immunology. Recurrent topics in Adina Figl's work include DNA Repair Mechanisms (2 papers), Cancer Genomics and Diagnostics (2 papers) and Cutaneous Melanoma Detection and Management (2 papers). Adina Figl is often cited by papers focused on DNA Repair Mechanisms (2 papers), Cancer Genomics and Diagnostics (2 papers) and Cutaneous Melanoma Detection and Management (2 papers). Adina Figl collaborates with scholars based in Germany, Sweden and Spain. Adina Figl's co-authors include Dirk Schadendorf, Kari Hemminki, Rajiv Kumar, Andreas Gast, Eduardo Nagore, P. Sivaramakrishna Rachakonda, Antje Sucker, Iris Moll, Susanne Horn and Christine Fischer and has published in prestigious journals such as Science, Cancer and International Journal of Cancer.

In The Last Decade

Adina Figl

8 papers receiving 1.6k citations

Hit Papers

TERT Promoter Mutations in Familial and Sporadic Melanoma 2013 2026 2017 2021 2013 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adina Figl Germany 7 909 535 389 285 187 8 1.6k
Barbara Heidenreich Germany 17 807 0.9× 453 0.8× 557 1.4× 296 1.0× 106 0.6× 27 1.6k
Siddhartha Deb Australia 20 660 0.7× 435 0.8× 158 0.4× 244 0.9× 189 1.0× 48 1.3k
Nadem Soufir France 22 877 1.0× 649 1.2× 109 0.3× 323 1.1× 178 1.0× 47 1.7k
Daniel Wai United States 22 945 1.0× 514 1.0× 182 0.5× 362 1.3× 89 0.5× 42 1.7k
Endi Wang United States 24 557 0.6× 546 1.0× 281 0.7× 101 0.4× 218 1.2× 127 2.0k
Nikolaos G. Kastrinakis Greece 8 1.6k 1.8× 814 1.5× 286 0.7× 347 1.2× 146 0.8× 8 2.0k
Susan J. Hsiao United States 18 615 0.7× 444 0.8× 135 0.3× 208 0.7× 163 0.9× 49 1.3k
David Cappellen France 21 1.6k 1.7× 545 1.0× 68 0.2× 277 1.0× 149 0.8× 50 2.3k
James Koh United States 16 944 1.0× 800 1.5× 137 0.4× 242 0.8× 117 0.6× 35 1.5k
Naotoshi Kanda Japan 19 1.0k 1.1× 296 0.6× 158 0.4× 306 1.1× 100 0.5× 40 1.7k

Countries citing papers authored by Adina Figl

Since Specialization
Citations

This map shows the geographic impact of Adina Figl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adina Figl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adina Figl more than expected).

Fields of papers citing papers by Adina Figl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adina Figl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adina Figl. The network helps show where Adina Figl may publish in the future.

Co-authorship network of co-authors of Adina Figl

This figure shows the co-authorship network connecting the top 25 collaborators of Adina Figl. A scholar is included among the top collaborators of Adina Figl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adina Figl. Adina Figl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Horn, Susanne, Adina Figl, P. Sivaramakrishna Rachakonda, et al.. (2013). TERT Promoter Mutations in Familial and Sporadic Melanoma. Science. 339(6122). 959–961. 1267 indexed citations breakdown →
2.
Eigentler, Thomas, Adina Figl, Dietmar Krex, et al.. (2010). Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma. Cancer. 117(8). 1697–1703. 99 indexed citations
3.
Figl, Adina, Dominique Scherer, Eduardo Nagore, et al.. (2010). Single-nucleotide polymorphisms in DNA-repair genes and cutaneous melanoma. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 702(1). 8–16. 26 indexed citations
4.
Herberth, Gunda, Joachim Heinrich, Stefan Röder, et al.. (2009). Reduced IFN‐γ‐ and enhanced IL‐4‐producing CD4+ cord blood T cells are associated with a higher risk for atopic dermatitis during the first 2 yr of life. Pediatric Allergy and Immunology. 21(1-Part-I). 5–13. 72 indexed citations
5.
Bouwhuis, Marna G., Andreas Gast, Adina Figl, et al.. (2009). Polymorphisms in the CD28/CTLA4/ICOS genes: role in malignant melanoma susceptibility and prognosis?. Cancer Immunology Immunotherapy. 59(2). 303–312. 52 indexed citations
6.
Scherer, Dominique, Eduardo Nagore, Justo Lorenzo Bermejo, et al.. (2009). Melanocortin receptor 1 variants and melanoma risk: A study of 2 European populations. International Journal of Cancer. 125(8). 1868–1875. 49 indexed citations
7.
Figl, Adina, Dominique Scherer, Eduardo Nagore, et al.. (2008). Single nucleotide polymorphisms in DNA repair genes XRCC1 and APEX1 in progression and survival of primary cutaneous melanoma patients. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 661(1-2). 78–84. 20 indexed citations
8.
Figl, Adina, Ranjit K. Thirumaran, Selma Ugurel, et al.. (2007). Multiple Melanomas After Treatment for Hodgkin Lymphoma in a Non-Dutch p16-Leiden Mutation Carrier With 2 MC1R High-Risk Variants. Archives of Dermatology. 143(4). 495–9. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026